CGT | 바이오모아

CGTBiologicstalePeproMene Bio, Inc.Phase 1

BAFFR-CAR T cells (BAFFR-CAR T cells)

Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+3

CGTBiologicstaleBioceltech Therapeutics, Ltd.Phase 1

BT-007 CD7 CAR-T cells (BT-007 CD7 CAR-T cells)

T Cell Lymphoblastic Lymphoma · T Cell Lymphoblastic Lymphoma

#TCellLymphoblasticLymphoma#CGT#Phase1#세포유전치료#CAR-T+2

CGTBiologicstaleKitePhase 2

other names: brexu-cel , Tecartus (Brexucabtagene autoleucel, Brexucabtagene autoleucel ( other names: brexu-cel , Tecartus))

Recurrent Mantle Cell Lymphoma; Refractory Mantle Cell Lymphoma · FRα

#FR#CGT#Phase2#세포유전치료#CAR-T+4

CGTBiologicstaleInstitute of Hematology & Blood…Phase 1

C-CAR066 (C-CAR066)

Diffuse Large B Cell Lymphoma · Diffuse Large B Cell Lymphoma

#DiffuseLargeBCellLymphoma#CGT#Phase1#세포유전치료#CAR-T+2

CGTBiologicstaleShanghai Exuma Biotechnology Lt…Phase 1

C402-CD19-CAR (C402-CD19-CAR)

Diffuse Large B-cell-lymphoma; DLBCL, Nos Genetic Subtypes · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+5

CGTBiologicstaleFred Hutchinson Cancer CenterPhase 1

C46/CCR5/P140K Lentiviral Vector-transduced Autologous HSPCs (C46/CCR5/P140K Lentiviral Vector-transduced Autologous HSPCs)

Human Immunodeficiency Virus 1 Positive; Stage I Adult Hodgkin Lymphoma · Human Immunodeficiency Virus 1 Positive

#HumanImmunodeficiencyVirus1Posit#CGT#Phase1#세포유전치료#CAR-T+3

임상시험 1상태 DISCONTINUED

CGTBiologicstaleBaylor College of MedicinePhase 1

C7R.CD30.CAR-EBVST cells (C7R.CD30.CAR-EBVST cells)

CD30-Positive Diffuse Large B-Cell Lymphoma; Anaplastic Large Cell Lymphoma, T Cell and Null Cell Type · CD30

#CD30#CGT#Phase1#세포유전치료#CAR-T+5

CGTBiologicstaleInstitute of Hematology & Blood…Phase 1

CAR T cells chimeric antigenreceptor cells (CAR T cells chimeric antigenreceptor cells)

Relapsed/Refractory B-cell Non-Hodgkin Lymphoma; Relapsed/Refractory B-cell ALL · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+4

CGTBiologicstaleM.D. Anderson Cancer CenterPhase 2

CAR T leukapheresis (CAR T leukapheresis)

Large B-cell Lymphoma; B-cell Lymphoma · Large B-cell Lymphoma

#LargeB-cellLymphoma#CGT#Phase2#세포유전치료#CAR-T+3

임상시험 1상태 DISCONTINUED

CGTBiologicstaleMedical College of WisconsinPhase 1

1.0 x10^5 CAR-20/19-T cells/kg (CAR-20/19-T cells, CAR-20/19-T cells (1.0 x10^5 CAR-20/19-T cells/kg))

Lymphoma, Non-Hodgkin; Lymphoma, B-Cell · Lymphoma, Non-Hodgkin

CGTBiologicstaleMedical College of WisconsinPhase 1

2.5 x10^5 CAR-20/19-T cells/kg (CAR-20/19-T cells, CAR-20/19-T cells (2.5 x10^5 CAR-20/19-T cells/kg))

Lymphoma, Non-Hodgkin; Lymphoma, B-Cell · Lymphoma, Non-Hodgkin

CGTBiologicstaleMedical College of WisconsinPhase 1

2.5 x10^6 CAR-20/19-T cells/kg (CAR-20/19-T cells, CAR-20/19-T cells (2.5 x10^6 CAR-20/19-T cells/kg))

Lymphoma, Non-Hodgkin; Lymphoma, B-Cell · Lymphoma, Non-Hodgkin

CGTBiologicstaleMedical College of WisconsinPhase 1

7.5 x10^5 CAR-20/19-T cells/kg (CAR-20/19-T cells, CAR-20/19-T cells (7.5 x10^5 CAR-20/19-T cells/kg))

Lymphoma, Non-Hodgkin; Lymphoma, B-Cell · Lymphoma, Non-Hodgkin

#BCMA#CGT#Preclinical#세포유전치료#CAR-T+4

CAR-BCMA T cell (CAR-BCMA T cell)

B Cell Lymphoma; B Cell Leukemia · BCMA

CGTBiologicstaleCARsgen Therapeutics Co., Ltd.Phase 2

CAR-CD19 T Cells (CAR-CD19 T Cells)

Refractory B-Cell Non-Hodgkin Lymphoma; Relapsed B-cell Non-Hodgkin Lymphoma · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4

#CD19#CGT#Preclinical#세포유전치료#CAR-T+4

CAR-CD19 T cell (CAR-CD19 T cell)

B Cell Lymphoma; B Cell Leukemia · CD19

효능 ORR 67%임상시험 1상태 ACTIVE

#BCellLymphoma#CGT#Preclinical#세포유전치료#CAR-T+3

CAR-CLD18 T cell (CAR-CLD18 T cell)

B Cell Lymphoma; B Cell Leukemia · B Cell Lymphoma